Agilent Technologies (NYSE:A) announced its quarterly earnings results on Monday, November 20th. The medical research company reported $0.67 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.62 by $0.05, Bloomberg Earnings reports. Agilent Technologies had a net margin of 15.30% and a return on equity of 16.96%. The firm had revenue of $1.19 billion during the quarter, compared to the consensus estimate of $1.17 billion. During the same period last year, the firm posted $0.59 EPS. The firm’s quarterly revenue was up 7.0% on a year-over-year basis. Agilent Technologies updated its Q1 guidance to $0.55-0.57 EPS and its FY18 guidance to $2.50-2.56 EPS.
Agilent Technologies (A) traded up $0.82 during trading on Thursday, reaching $66.71. 2,294,513 shares of the company traded hands, compared to its average volume of 1,866,067. Agilent Technologies has a twelve month low of $44.77 and a twelve month high of $70.93. The company has a market cap of $21,185.94, a price-to-earnings ratio of 27.78, a price-to-earnings-growth ratio of 1.99 and a beta of 1.27. The company has a quick ratio of 2.85, a current ratio of 3.30 and a debt-to-equity ratio of 0.37.
The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, January 24th. Investors of record on Tuesday, January 2nd will be paid a dividend of $0.149 per share. This is a positive change from Agilent Technologies’s previous quarterly dividend of $0.13. The ex-dividend date is Friday, December 29th. This represents a $0.60 annualized dividend and a yield of 0.89%. Agilent Technologies’s dividend payout ratio (DPR) is presently 25.24%.
Several brokerages recently issued reports on A. ValuEngine downgraded shares of Agilent Technologies from a “buy” rating to a “hold” rating in a report on Friday, December 1st. Robert W. Baird restated a “buy” rating and issued a $72.00 price objective on shares of Agilent Technologies in a research report on Friday, November 24th. Cowen restated a “hold” rating and issued a $70.00 price objective on shares of Agilent Technologies in a research report on Wednesday, November 22nd. Barclays raised their price objective on shares of Agilent Technologies from $67.00 to $71.00 and gave the company an “overweight” rating in a research report on Tuesday, November 21st. Finally, J P Morgan Chase & Co raised their price objective on shares of Agilent Technologies to $75.00 and gave the company an “overweight” rating in a research report on Tuesday, November 21st. Six equities research analysts have rated the stock with a hold rating and ten have given a buy rating to the company’s stock. The company presently has an average rating of “Buy” and an average target price of $68.34.
In other Agilent Technologies news, CEO Michael R. Mcmullen sold 16,492 shares of Agilent Technologies stock in a transaction that occurred on Thursday, September 14th. The shares were sold at an average price of $65.33, for a total value of $1,077,422.36. Following the transaction, the chief executive officer now owns 211,872 shares of the company’s stock, valued at $13,841,597.76. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, VP Mark Doak sold 4,154 shares of Agilent Technologies stock in a transaction that occurred on Tuesday, December 5th. The shares were sold at an average price of $67.00, for a total transaction of $278,318.00. Following the completion of the transaction, the vice president now directly owns 68,270 shares in the company, valued at approximately $4,574,090. The disclosure for this sale can be found here. Insiders have sold a total of 155,268 shares of company stock worth $10,637,706 in the last three months.
TRADEMARK VIOLATION NOTICE: This piece was first posted by The Lincolnian Online and is owned by of The Lincolnian Online. If you are accessing this piece on another domain, it was copied illegally and reposted in violation of US & international copyright laws. The correct version of this piece can be read at https://www.thelincolnianonline.com/2017/12/07/agilent-technologies-inc-a-posts-earnings-results-beats-expectations-by-0-05-eps-updated-updated-updated-updated.html.
Agilent Technologies Company Profile
Agilent Technologies, Inc provides application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. The Company serves the life sciences, diagnostics and applied chemical markets. It has three business segments: life sciences and applied markets business, diagnostics and genomics business, and Agilent CrossLab business.
Receive News & Ratings for Agilent Technologies Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies Inc. and related companies with MarketBeat.com's FREE daily email newsletter.